Paz Rodríguez Ausín
Nicolás López Ferrando
Mª José León Cabello
Nuria Valdés Sanz
In recent years, endothelial lamellar keratoplasty (ELK or DSAEK) has been incorporated into routine practice as a treatment for endothelial pathology in the absence of corneal stromal lesions. The results of the ELK can be studied according to several anatomical or functional aspects. On the other hand, it is interesting to compare the results of this technique with those of other options such as penetrating keratoplasty (PK) or Descemet-endothelial keratoplasty (DEK or DMEK).
GLOBAL RESULTS
Graft survival: Transparent ELK percentages were calculated at 5 years in 92%4, at 3 years in 94%6, and with follow-ups between 1 month and 3 years in 97.5%9.
Functional results: best-corrected visual acuity (BCVA) and induced refractive change. Outstanding means of BCVA published were 0.45 ± 0.39 at 12 months1, 0.53 ± 0.30 with follow-ups between 1 and 36 months2, or 0.63 at 12 months3. The percentage of VA ≥ 0.5 varies between 38 and 100%4,5. The correlation between graft thickness and BCVA was initially low2, but later the same group reported BCVA of 0.80 ± 0.16 at 3 months in 60 cases with the ultrafine ELK technique (99.33 ± 16.97 mm)6. ELK induces an average hyperopia of 1 diopter (D), which should be considered in the combined procedures of cataract and ELK. The average induced cylinder is 0.11 D (between -0.4 and +0.6 D).
Complications
• Dislocation of the donor lenticule: It is the most frequent complication and usually occurs in the first 24 hours. Percentages of reformation of the bubble have been published between 0 and 82%3,4,6,7-9 with an average around 10%. In eyes without capsular support, the frequency doubles9.
• Graft rejection: In a 2-year review the percentages range between 0 and 14%4. Price et al10 report a 3-year rejection probability of 9%.
• Primary failure of the graft: Defined as a graft that does not achieve transparency during the first 2 months, its frequency ranges from 0 to 29%3,4,7,9 with an average of 5%.
• Endothelial cell loss: At 3 years the average percentage of loss is 39-46%4,6,9. It would be higher if it was necessary to reinject air, with small incisions (3.2 mm) and novice surgeons. Comparative studies of the technique of introduction of the graft do not show significant differences between slider plus forceps and an injector (Endosaver)7,11.
• Other complications: Intraocular hypertension in the immediate postoperative period due to pupillary blockage by air in the anterior chamber (0.1-9.5%)4,7,9, epithelial growth in the interphase (0.8-1.6%), infections (0.8-1.5%).
RESULTS ACCORDING TO PATHOLOGIES
Fuchs’ dystrophy is the most frequent indication of ELK in some important series. In general, it has the best results. Graft survival at five years varies from 90% to 96%12-14, with an immunological rejection rate of 5%, versus 16% in PK due to this indication12.
Pseudophakic or aphakic corneal edema (Figure 1) leads the causes of secondary endothelial dysfunction and is the most frequent in Asian eyes14,15. The mean survival of the graft at 1, 2, 3 and 5 years is 94%, 88%, 87% and 76% respectively, significantly lower than in Fuchs' dystrophy (95% at 5 years).
Figure 1: a) Successful ELK at 2 weeks, in a case of pseudophakic edema. b) The OCT shows a 100 μm lamellar graft, cut in the tissue bank.
In cases with glaucoma, 5-year survival is especially low in operated eyes, either by trabeculectomy or drainage device (40%), compared to non-operated ones (95%)13. In another 20-month study, secondary failure of the graft was also greater in eyes operated on for glaucoma (15.0%) compared to non-operated eyes (3.2%).
The results of the ELK re-grafts seem to be comparable to those of the primary ELK17. In a study of 113 failed PKs, survival was better in the group treated by ELK (96.2% per year and 86.4% at 5 years) than after a new PK (91.9% and 51.3%). respectively)18. In cases of PK after CMV endothelitis (with positive aqueous humor PCR), recurrences in the graft occur between 3 and 11 months, while immunological rejection usually occurs between 12 and 18 months19.
The results in other primary endothelial dysfunctions such as hereditary congenital endothelial dystrophy, posterior polymorphic dystrophy, iridocorneal endothelial syndrome, endothelial failure secondary to phakic lenses or Sato’s radial anterior and posterior keratotomy and in xeroderma pigmentosum, are generally favorable, although they are anecdotal cases or short series.
RESULTS COMPARED WITH PENETRATING KERATOPLASTY
There are no controlled studies comparing ELK and PK. In the available retrospective studies, ELK appears as a procedure with fewer complications and, in the event of occurrence, less serious than in PK10,20. We find 5 key points:
Economic factors
If one considers the possibility of obtaining pre-cut tissue in the eye bank and obviate the need for the microkeratome, the cost-effectiveness of the ELK would be higher than that of the PK, apart from requiring less postoperative consultations and added procedures21.
Factors of the surgical technique
Although mastering ELK requires overcoming a learning curve, a series of advantages inherent in the technique – such as working in a “closed sky”, the possibility of using topical anesthesia, the almost absence of sutures, etc. – make it for many surgeons preferable to PK.
Rejection and survival
Price and Gorovoy10 presented a non-randomized multicenter trial in 2013, in which graft survival and endothelial loss at 3 years was similar in ELK and PK. The endothelial loss in ELK would be greater than after PK during the first 6 months, but later it stabilizes and in the long run it is lower than in PK. Rejection appears less frequently in ELK and has a better prognosis than in PK25. It is usually asymptomatic, with little clinical and milder symptoms, which is attributed to the prolonged use of corticosteroids in ELK and the absence of complications related to the sutures and healing26. Operating the second eye within the first year after the first did not increase the risk of rejection of the ELK, unlike what is known in PK27.
Complications
Apart from rejection, the main complications of PK result from problems related to penetrating trepanation: need for sutures, scarring and ocular surface problems, such as persistent epithelial defects or neurotrophic ulcers (Figure 2), weakness in trauma, high astigmatism or irregular and late refractive changes. The ELK avoids all these and presents as a specific complication the dislocation of the disc, also related to the learning curve. PK and ELK have in common some complications, such as primary failure, progressive endothelial loss without apparent rejection and infections – with the particularity of the location at the interface in the second –. The risk of massive supra-choroidal hemorrhage is greater in an open globe – as well as its consequences – and the only case reported during an ELK preserved the vision22.
Figure 2: Neurotrophic ulcer in a PK performed 2 months earlier for pseudophakic edema in a diabetic patient.
Recovery and visual quality
The published data are clear regarding the superiority of ELK over PK in terms of visual rehabilitation time, although there would be no differences in terms of the final BCVA23. Post-operative ametropia after PK is usually significant, especially with high astigmatism, compared to the discrete hyperopic change after ELK. The quality of vision, in terms of high-order aberrations, appears superior in ELK24.
RESULTS IN COMPARISON WITH DESCEMETO-ENDOTHELIAL KERATOPLASTY
Despite the abundant literature on ELK, and to a lesser extent, on DEK (DMEK), there are few comparative studies between the two. However, differences have been noted in the following aspects:
Graft detachment
Although it has been suggested that thinner grafts in ELK are more likely to dislocate, this would not be directly applicable to DEK. Although in general there are higher rates of detachment in the DEK, it seems that the main factor is the experience of the surgeon28,32. When this is experienced, values similar to those of the ELK are reached in some studies30.
Complications and rejection
DEK has shown a higher frequency of air reformations, primary graft failure, and greater tissue losses during its preparation. To limit this last problem, there are eye banks that remit DM-endothelium already dissected29,34. ELK has shown a lower risk of rejection than PK, but with DEK it would be even lower35.
Endothelial cell loss
As shown by the different studies in each technique, striking falls in endothelial cell density occur in the immediate postoperative period, especially the first 3 months. However, in comparative studies, losses with both techniques are equal at 6 months in 35%28,30,34.
Visual recovery and refraction
In theory, DEK should have better visual results by not providing a stroma-stroma interface, but the direct apposition of Descemet’s membrane (DM) on the overlying stroma. Studies on ELK have shown smaller and slower visual recoveries than studies on DEK28,29. Although these differences have been confirmed in comparative studies between the two techniques, VA after ELK continues to improve in the long-term studies (3 years) and approaches the DEK data30. In any case, the results at 1-year favor DEK28,32,34, and patients who undergo a technique in each eye prefer this technique and would recommend it to their relatives31,33. DEK generates a minimum hyperopic change, lower than that produced with ELK. Furthermore, with DEK, fewer high-order aberrations are generated36.
Media and training
ELK (DSAEK) requires more means and more expensive than DEK, whether it is invested in material or if the pre-cut tissue is acquired. This makes the second technique applicable in almost anywhere in the world28. In contrast, its results depend to a large extent on the experience of the surgeon, but not in ELK, in which novice surgeons can quickly obtain good results and acceptable complication rates29.
BIBLIOGRAPHY
1. Van den Biggelaar F, Cheng Y, Nuijts R, Shouten J, Wijdh R, Pels E, Van Cleynenbreugel H, Eggink C, Rijneveld W, Dirksen C. Economic Evaluation of endothelial keratoplasty techniques and penetrating keratoplasty in the Netherlands. Am J Ophthalmol. 2012; 154: 272-281.
2. Villarrubia A, Palacín E, Aránguez C, Solana J, García-Alonso. Resultados funcionales tras queratoplastia endotelial: tres años de experiencia. Arch Soc Esp Oftalmol. 2011; 86: 47-53.
3. Guerra F, Anshu A, Price M, Price F. Endothelial keratoplasty: fellow eyes comparison of Descemet stripping automated endothelial keratoplasty and Descemet membrane endothelial keratoplasty. Cornea. 2011; 30: 1382-1386.
4. Maier P, Reinhard T, Cursiefen C. Descemet stripping endothelial keratoplasty-rapid recovery of visual acuity. Dtsch ArzteblInt. 2013; 110: 365-371.
5. Vira S, Abugo U, Shih C, Udell IJ, Sperling B, Hannush SB, Basti S, Bouchard CS. Descemet stripping endothelial keratoplasty for the treatment of combined Fuchs corneal endothelial dystrophy and Keratoconus. Cornea. 2014; 33: 1-5.
6. Villarrubia A, Cano-Ortiz A. Development of a nomogram to achieve ultrathin donor corneal disks for Descemet-stripping automated endothelial keratoplasty. J Cataract Refract Surg. 2015; 41: 146-151.
7. Elbaz U, Yeung SN, Lichtinger A, Zauberman NA, Goldich Y, Ziai S, Chan CC, Rootman DS, Slomovic AR. Endoglide versus endosaver for the insertion of donor graft in Descemet stripping automated endothelial keratoplasty. Am J Ophthalmol. 2014; 158: 257-262.
8. Terry MA, Straiko MD, Goshe JM, Shamie N, Shah A, Alqudah AA, Davis-Boozer D. Endothelial keratoplasty: prospective, randomized, masked clinical trial comparing an injector with forceps for tissue insertion. Am J Ophthalmol. 2013; 156: 61-68.
9. Villarrubia A, Palacín E, Aránguez C, Solana J, García-Alonso CR. Complicaciones tras queratoplastia endotelial: tres años de experiencia. Arch Soc Esp Oftalmol. 2011; 86: 180-186.
10. Price MO, Gorovoy M, Price FW, Benetz BA, Menegay HJ, Lass JH. Descemet’s stripping automated endothelial keratoplasty. Three-year graft and endothelial cell survival compared with penetrating keratoplasty. Ophthalmology. 2013; 120: 246-251.
11. Riaz KM, Grewal DS, Cervantes P, Basti S. Endothelial damage with two DSAEK insertion techniques performed by a novice. Cornea. 2014; 33: 91-95.
12. Hjortdal J, Pedersen IB, Bak-Nielsen S, Ivarsen A. Graft rejection and graft failure after penetrating keratoplasty or posterior lamellar keratoplasty for Fuchs endothelial dystrophy. Cornea. 2013; 32: 60-63.
13. Price MO, Fairchild KM, Price D et al. Descemet’s stripping endothelial keratoplasty. Five-year graft survival and endothelial cell loss. Ophthalmology 2011; 118: 725-729.
14. Ang M, Mehta Js, Lim F et al. Endothelial cell loss and graft survival after Descemet’s stripping automated endothelial keratoplasty and penetrating keratoplasty. Ophthalmology. 2012; 119: 2239-2244.
15. Nakatani S y Murakami A. Three-year outcome of Descemet stripping automated endothelial keratoplasty for bullous keratopathy after argon laser iridotomy. Cornea. 2014; 33: 780-784.
16. Aldave A J, Chen JL, Zaman AS et al. Outcomes after DSEK in 101 eyes with previous trabeculectomy and tube shunt implantation. Cornea. 2014; 33: 223-229.
17. Kim P, Yeung SN, Lichtinger A et al. Outcomes of repeat endothelial keratoplasty in patients with failed Descemet stripping endothelial keratoplasty. Cornea. 2012; 31: 1154-1157.
18. Ang M, Ho H, Wong C et al. Endothelial keratoplasty after failed penetrating keratoplasty: an alternative to repeat penetrating keratoplasty. Am J Ophthalmol. 2014; 158: 1221-1227.
19. Ang M; Sng CCA, Chee S et al. Outcomes of corneal transplantation for irreversible corneal decompensation secondary to corneal endothelitis in Asian eyes. Am J Ophthalmol. 2013; 156: 260-266.
20. Bahar I, Kaiserman I, Levinger E, Sansanayudh, Slomovic AR, Rootman DS. Retrospective contralateral study comparing Descemet stripping automated endothelial keratoplasty with penetrating keratoplasty. Cornea. 2009; 28: 485-488.
21. Prabhu SS, Kaakeh R, Sugar A, Smith DG, Shtein RM. Comparative cost-effectiveness analysis of Descemet stripping automated endothelial keratoplasty versus penetrating keratoplasty in the United States. Am J Ophthalmol. 2013; 155: 45.
22. Suh LH, Yoo SH, Deobhakta A, Donaldson KE, Alfonso EC, Culbertson WW, O’Brien TP. Complications of Descemet’s stripping with automated endothelial keratoplasty: survey of 118 eyes at One Institute. Ophthalmology. 2008; 115: 1517-1524.
23. Nanavaty MA, Wang X, Shortt AJ. Endothelial keratoplasty versus penetrating keratoplasty for Fuchs endothelial dystrophy. Cochrane Database Syst Rev. 2014; Feb14.
24. Salvetat ML, Zeppieri M, Miani F, Brusini P. Postkeratoplasty anterior and posterior corneal surface wavefront analysis: Descemet’s stripping automated endothelial keratoplasty versus penetrating keratoplasty. ISRN Ophthalmol. 2013; Sep12.
25. Allan BD, Terry MA, Price FW Jr, Price MO, Griffin NB, Claesson AM. Corneal transplant rejection rate and severity after endothelial keratoplasty. Cornea. 2007; 26: 1039-1042.
26. Jordan CS, Price MO, Trespalacios R, Price FW Jr. Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part one: clinical signs and symptoms. Br J Ophthalmol. 2009; 93: 387-390.
27. Price MO, Jordan CS, Moore G, Price FW Jr. Graft rejection episodes after Descemet stripping with endothelial keratoplasty: part two: the statistical analysis of probability and risk factors. Br J Ophthalmol. 2009; 93: 391-395.
28. Dapena I, Ham L, Dirisamer M, Melles GRJ. DMEK: Resultados y comparación con DSEK/DSAEK. En: Villarrubia Cuadrado A (Ed): Trasplante de endotelio corneal. Sociedad Española de Oftalmología. Madrid, 2010.
29. Tourtas T, Laaser K, Bachmann BO, Cursiefen C, Kruse FE. Descemet membrane endothelial keratoplasty versus Descemet stripping automated endothelial keratoplasty. Am J Ophthalmol. 2012; 153: 1082-90.
30. Terry MA. From PK to DLEK to DSAEK to DMEK. What have we gained and what have we risked? En: Villarrubia Cuadrado A (Ed): Trasplante de endotelio corneal. Sociedad Española de Oftalmología. Madrid, 2010.
31. Guerra FP, Anshu A, Price MO, Price FW. Endothelial keratoplasty: fellow eyes comparison of Descemet stripping automated endothelial keratoplasty and Descemet membrane endothelial keratoplasty. Cornea. 2011; 30: 1382-1386.
32. Dapena I, Ham L, Melles GR. Endothelial keratoplasty: DSEK/DSAEK or DMEK -the thinner the better? Curr Opin Ophthalmol. 2009; 20: 299-307.
33. Goldich Y, Showail M, Avni-Zauberman N, Perez M, Ulate R, Elbaz U, Rootman DS. Contralateral eye comparison of Descemet membrane endothelial keratoplasty and Descemet stripping automated endothelial keratoplasty. Am J Ophthalmol. 2015; 159: 155-159.
34. Price MO, Giebel AW, Fairchild KM, Price FW Jr. Descemet’s membrane endothelial keratoplasty: prospective multicenter study of visual and refractive outcomes and endothelial survival. Ophthalmology. 2009; 116: 2361-8.
35. Anshu A, Price MO, Price FW Jr. Risk of corneal transplant rejection significantly reduced with Descemet’s membrane endothelial keratoplasty. Ophthalmology. 2012; 119: 536-540.
36. Rudolph M, Laaser K, Bachmann BO, Cursiefen C, Epstein D, Kruse FE. Corneal higher-order aberrations after Descemet’s membrane endothelial keratoplasty. Ophthalmology. 2012; 119: 528-535.